Uncategorized

BARCELONA, Spain, March 2, 2026 /PRNewswire/ -- TECNO, the AI-driven technology brand, today unveiled its new AI investment strategies at...

CHARLOTTE, N.C., March 2, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility,...

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that...

TAMPA, Fla. and STAMFORD, Conn., March 2, 2026 /PRNewswire/ - Primo Brands Corporation (NYSE: PRMB) ("Primo Brands" or the "Company"), today announced...

84 Lumber Celebrates Women in Construction Week 2026 by Spotlighting Female Leaders Across the IndustryEIGHTY FOUR, Pa., March 2, 2026...

- Launched "dabogratinib 3x3" strategy to pursue 3 late-stage clinical studies in LG-UTUC, IR NMIBC and ACH, 3 potential blockbuster indications...

Successfully started 216 patients on IBTROZI® (taletrectinib) in the fourth quarter of 2025, for a total of 432 new patient...

NEWTON, Mass., March 2, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,...

LAUSANNE, Switzerland, March 2, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the...

Prioritizing three key, late-stage clinical programs including Molecular Degrader of Extracellular Proteins (MoDETM) and Targeted Removal of Aberrant Protein (TRAPTM) extracellular...